everolimus
Everolimus is currently used as an immunosuppressant to prevent rejection of organ transplants. It is a derivative of Rapamycin, and works similarly to Rapamycin as an mTOR inhibitor. Reference standards of Everolimus API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => 2-((tert-Butyldimethylsilyl)oxy)ethyl 2,2,2-trichloroacetimidate
[catalogue_number] => PA 05 73530
[category_ids] => ,84,
[chemical_name] =>
[weight] => 320.72
[form] => C10H20Cl3NO2Si
[cas] => NA
[pslug] => 2-tert-butyldimethylsilyl-oxy-ethyl-2-2-2-trichloroacetimidate-pa0573530
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
2-((tert-Butyldimethylsilyl)oxy)ethyl 2,2,2-trichloroacetimidate
Catalogue No.:PA 05 73530
Molecular Formula : C10H20Cl3NO2Si
Molecular Weight : 320.72